Zhejiang University
Clinical trials sponsored by Zhejiang University, explained in plain language.
-
Experimental CAR-T therapy shows promise in small leukemia trial
Disease control CompletedThis early-phase trial tested a new CAR-T cell therapy called ThisCART19A in 10 adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The main goals were to check safety and find the right dose. Researchers tracked side effects and how well the treatment…
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New combo aims to stop liver cancer recurrence in High-Risk patients
Disease control CompletedThis early-stage trial tested whether combining donafinib (a targeted therapy) with an anti-PD-1 antibody (an immunotherapy) can safely prevent liver cancer from coming back after surgery. It involved 30 patients with high-risk features like microvascular invasion or multiple tum…
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New combo therapy aims to tackle tough pancreatic cancer
Disease control CompletedThis completed phase 2 trial tested whether adding an anti-PD-1 immunotherapy drug to standard chemotherapy (modified-FOLFIRINOX) helps patients with locally advanced or borderline resectable pancreatic cancer. The study enrolled 392 participants and compared the combination agai…
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New maintenance therapy shows promise in preventing T-Cell cancer relapse after transplant
Disease control CompletedThis study tested whether a low dose of the drug chidamide, given after a donor stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four patients aged 14 to 70 who were at high risk of relapse took part. The main g…
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo device aims to keep patients breathing safely during lung scope
Symptom relief CompletedThis study tested a new device called the COMBO Endoscopy Oropharyngeal Airway in 104 adults undergoing a sedated lung procedure (fiberoptic bronchoscopy). The device combines oxygen delivery, airway support, and breathing monitoring into one tool. The goal was to see if it could…
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can a nasal oxygen device prevent low oxygen during endoscopy in sleep apnea patients?
Symptom relief CompletedThis study tested whether a high-flow nasal cannula (HFNC) can reduce the risk of low oxygen levels during sedated gastrointestinal endoscopy in 80 adults with high-risk obstructive sleep apnea. Participants had a STOP-Bang score of 5 or higher and were undergoing gastroscopy, co…
Phase: NA • Sponsor: Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Mindfulness may spark creative thinking in scientists
Knowledge-focused CompletedThis study explores whether two types of mindfulness meditation—focused attention and open monitoring—can improve creativity in graduate students and academic researchers. Over five days, participants practice meditation or listen to audio stories, then take tests measuring diver…
Phase: NA • Sponsor: Zhejiang University • Aim: Knowledge-focused
Last updated Jul 02, 2026 01:00 UTC
-
3D maps may sharpen prostate cancer detection
Knowledge-focused CompletedThis study tested whether using 3D reconstructed images of the pelvis can help doctors perform more precise prostate biopsies. A total of 436 men with suspicious prostate lesions took part. Researchers compared standard biopsy methods with a 3D imaging-assisted approach to see if…
Sponsor: Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC